NCT04712149

Pilot Digital Follow-up of Lung Cancer

Completed NA Last updated 15 January 2021

What this trial tests

NA trial testing Weekly digital follow up in Lung Cancer in 30 participants. Completed in 31 July 2020.

Timeline

1 February 2019

Primary endpoint
31 July 2020

31 July 2020

Quick facts

Lead sponsor	Hasselt University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	30
Start date	1 February 2019
Primary completion	31 July 2020
Estimated completion	31 July 2020
Sites	1 location across Belgium

Drugs / interventions tested

• Weekly digital follow up

Conditions studied

• Lung Cancer — all drugs for Lung Cancer →

Sponsor

Hasselt University

Who can join

18 and older, any sex, with Lung Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the pilot study, 30 patients with metastatic lung cancer (stage IV) will be recruited at the start of their stage IV treatment from February 2019. The study period per patient will last six months, from the start of the stage IV treatment. Patients are eligible if they are diagnosed with stage IV lung cancer, speak sufficient Dutch, and are willing to participate. Patients are randomly assigned to two arms by simple randomization. In the intervention arm, 15 patients will receive a weekly questionnaire. Alerts will be sent to the multidisciplinary care team, who will undertake follow-up actions. In the control arm, 15 patients will receive the standard care pathway without weekly questionnaire and without automatic alerts to the care team. The standard care pathways and the care team are the same in both groups. In this pilot study, the weekly follow-up will be evaluated by a validation questionnaire, semi-structured interviews with patients (n=5) and the care team (n=5), and workload registration of the care team during a six-month period for all included patients in the pilot.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Evaluation of the implementation of Value-Based Healthcare with a weekly digital follow-up of lung cancer patients in clinical practice.
   Misplon S, Marneffe W, Himpe U, Hellings J, et al · · 2022 · cited 4× · PMID 35819130 · DOI 10.1111/ecc.13653